EFFECTS OF GALLOPAMIL ON EPINEPHRINE AND NOREPINEPHRINE PLASMATIC LEVELS AND ON TXB(2) AND BETA-TG RELEASE IN PATIENTS WITH CORONARY-ARTERYDISEASE DURING ADRENERGIC STIMULUS WITH COLD PRESSOR TEST
A. Saitta et al., EFFECTS OF GALLOPAMIL ON EPINEPHRINE AND NOREPINEPHRINE PLASMATIC LEVELS AND ON TXB(2) AND BETA-TG RELEASE IN PATIENTS WITH CORONARY-ARTERYDISEASE DURING ADRENERGIC STIMULUS WITH COLD PRESSOR TEST, Pharmacological research, 32(1-2), 1995, pp. 49-55
We investigated the effect of gallopamil administration during a cold
presser test (CPT) in 18 patients suffering from chronic angina (CA) a
nd in 21 healthy subjects. CA patients showed increased basal levels o
f beta-thromboglobulin and thromboxane B-2 compared to control patient
s and normal plasma levels of catecholamines. CPT caused plasma catech
olamines, beta-thromboglobulin and TxB(2) levels to rise. This rise wa
s greater in CA patients than in control patients. Administration of g
allopamil (50 mg kg(-1) three times a day for 30 days) reduced plasma
levels of catecholamines, beta-thromboglobulin and TxB(2) blood concen
trations either under basal conditions or after CPT. Our data suggest
that gallopamil is able to modulate the response induced by adrenergic
stress. (C) 1995 The Italian Pharmacological Society